Press release
Ketamine treatment Market Share, Trends, Growth, Analysis and Forecast 2023-2030
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/ketamine-treatment-market
The primary factor supporting the market growth includes the growing demand and advancements in telehealth. Post-COVID-19 pandemic, the number of people receiving ketamine via telemedicine has been soared owing to the lockdown restrictions imposed globally by the federal government of all the nations. One rule change allowed providers to prescribe controlled substances including ketamine without first seeing the patient in person.
The adoption of telemedicine and virtual care solutions is a significant driving factor in the globally ketamine treatment market. It increases access to treatment, especially in areas where in-person options are minimal. For instance, in September 2022, Braxia Scientific Corp. launched KetaMD in Florida. KetaMD accepted new patients and finished their first ketamine treatments. Eligible patients, as determined by one of KetaMD's certified Florida healthcare practitioners, received medically supervised therapies while at home, virtually directed by registered nurses with mental health competence.
Furthermore, Ketamine has been studied for its potential in treating depression and other mood disorders which have not responded to other forms of treatment. It has been seen to offer a possible solution to those struggling with treatment-resistant conditions. in October 2023,Victoria's first public ketamine clinic has opened It is employing the anesthetic, that is often used as a recreational substance, to assist patients suffering from difficult-to-treat depression.
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Route of Administration
o By Application
o By End User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- includes Core One Labs Inc., Enso Discoveries, LLC., Johnson & Johnson Pvt. Ltd., Ketamine Research Institute, Ketamine Wellness Centers, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Ketamine Treatment Market Report Segment
By Route of Administration
• Oral
• Infusions
• Nasal Spray
By Application
• Treatment-Resistant Depression (TRD)
• Anxiety Disorder
• Post-Traumatic Stress Disorder (PTSD)
• Others (Anesthesia and Sedation, Bipolar Depression, and Chronic Pain Management)
By End-User
• Hospitals and Medical Centers
• Specialized Ketamine Clinics
• Psychiatric Hospitals
• Others (Rehabilitation Centers, Primary Care Physicians, Individual Patients and Research and Academic Institutions)
A full report of Ketamine treatment Market available @ https://www.omrglobal.com/industry-reports/ketamine-treatment-market
Global Ketamine treatment Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
Company Profiles
• Core One Labs Inc.
• Enso Discoveries, LLC.
• Johnson & Johnson Pvt. Ltd.
• Ketamine Research Institute
• Ketamine Wellness Centers
• Klarisana
• Koch Industries, Inc.
• Mindbloom, Inc.
• Pfizer
• saveminds.co.uk
• Stella MSO LLC
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ketamine treatment Market Share, Trends, Growth, Analysis and Forecast 2023-2030 here
News-ID: 3347169 • Views: …
More Releases from Orion Market Research
Sterile Solution for Injection Market Size, Trends, Latest Insights, Analysis an …
The global Sterile Solution for Injection Market is expected to grow at a significant CAGR during the forecast period. The sterilized solution is used to mix infant formula for babies, dilute or dissolve water-soluble medications for injections, and mix infant formula for persons with impaired immune systems. It is mostly utilised in medical settings since it cannot transmit infections. Although sterile water is occasionally distilled, it is not the same…
Stem Cell and Platelet Rich Plasma Alopecia Therapies Market Analysis and Future …
The global stem cell and platelet rich plasma alopecia therapies market is expected to grow at a significant CAGR during the forecast period. Increased need for accurate and rapid alopecia treatment, as well as breakthroughs in platelet rich plasma and stem cell therapies that have transformed diagnostic technology, which is expected to drive the market forward. Furthermore, the global market is likely to be driven by an increase in awareness…
STD Home Testing Market Size, Trends, Latest Insights, Analysis and Forecast 202 …
The global STD home testing market is anticipated to grow at a considerable CAGR of around 4.7% during the forecast period. More than 30 different bacteria, viruses, and parasites are transmitted through sexual contact. Eight of these pathogens are linked to the greatest incidence of sexually transmitted disease, which include syphilis, gonorrhea, Chlamydia, trichomoniasis, hepatitis B, herpes simplex virus, HIV, and human papillomavirus (HPV). According to the National Center for…
Staphylococcal Infection Drug Market Is Expected To Exhibit Significant Growth O …
The global staphylococcal infection drug market is expected to grow at a significant CAGR during the forecast period. The presence of single infectious staph in the environment can lead to an increase in the use of anti-staphylococcal medications among people. Staphylococcus infection is a form of bacterial infection that can live within the nose or on the skin. This disease is communicable, and it is the cause of an increase…
More Releases for Ketamine
Ketamine Market 2022 Emerging Players, Growth Analysis and Precise Outlook | Seq …
The Global Ketamine Market report focuses on a comprehensive analysis of the recent and future prospects of the Ketamine industry. An in-depth analysis of historical trends, future trends, SWOT analysis, demographics, industrial advances, and regulatory requirements for the market has been performed to analyze the growth rate of each segment and sub-segment. The growth of the Ketamine market was essentially driven by the increasing R&D spending across the world. The…
Rising Demographic Trends In Elderly Population Boost Injectable Ketamine Market …
The Recent study by Fact.MR- (leading business and competitive intelligence provider) On global Injectable Ketamine market Survey study presents an all in all compilation of the historical, current and future outlook of Injectable Ketamine market as well as the factors responsible for such a Injectable Ketamine Market growth.
The report on the market survey of Injectable Ketamine gives estimations of the Size of Injectable Ketamine Market and the overall share of…
U.S. Psychedelic Drugs Market 2021| Industry Size, Share, Demand, Manufacturers …
U.S. Psychedelic Drugs Market research analysis report starts with a basic introduction of the 2021 market segmentation, future scenario, Industry growth rate, and industrial opportunities to 2028. The company profile section has parameters such as company synopsis, commercial synopsis, work strategy and planning, SWOT analysis, and present developments. With the study of competitor analysis, the Industry can get the know-how of the strategies of key players in the market that…
Psychedelic Drugs Market By top key Players are Phencyclidine, Gamma Hydroxybuty …
One of the utmost and quickest ways to collect information for the business in this fast-paced industry is Psychedelic Drugs Market research or secondary research. This Psychedelic Drugs Market
research report makes available state-of-the-art information about the entire market along with the holistic view of the market. It also assesses the Psychedelic Drugs Market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors…
Increasing Trend of Onsite Clinic Market 2019 Trend and Forecast with Top Player …
Onsite Clinic Market: Employers are looking for ways to reduce their associated costs while maintaining a healthy workforce, and field clinics are a useful resource for managing chronic diseases and promoting good health.
On-site health clinics are evolving to address these and other challenges faced by employers seeking to support a healthy workforce while reducing health care costs. According to a 2015 survey by Benefits Consultant Mercer, nearly 30% of companies…
New Detailed Review of Oral Ketamine for Depression Published in JCP
Memphis, TN (April 16, 2019) – A review article published today in The Journal of Clinical Psychiatry indicates that orally administered ketamine is efficacious for depression but may take longer to yield results. The review, authored by Joshua D. Rosenblat and colleagues at the University of Toronto, analyzed 13 articles, including 2 randomized controlled trials (RCTs).
The RCTs demonstrated antidepressant efficacy and good tolerability for oral ketamine, but significant changes…
